AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
This piece highlights which crypto has the smallest price swings and what that means for portfolio balance, risk management, and returns.
28,114 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
NVIDIA riding robust AI demand, elevated data-center spending, and resilient margins as 2026 unfolds. Analysts weigh ...
Newmont Mining stock rebounded on Friday as gold prices rallied and investors rotated into safe-haven assets. This gu...
Oil hovers around 110 per barrel on May 12, 2026, signaling continued volatility amid global supply pressures and sum...
As Treasury yields rise, SPHD's monthly distributions remain a focal point for income investors. This dividend safety...
Eli Lilly faces a pivotal year as its GLP-1 franchise powers revenue growth and new oral therapies expand addressable...
Oregon's push to shift recycling costs to manufacturers promised cleaner streets and better recycling, but the rollou...
Palantir Technologies has delivered a staggering 625% rally since 2020, but a mix of government ties and governance s...
OpenAI CEO Sam Altman faces cross-examination in a federal court case brought by Elon Musk, defending his leadership ...
Markets react to a surprising Air Force One seat allocation featuring Nvidia’s CEO, sparking chatter that export lice...
The AI-driven semiconductor surge is cooling into a profitability-driven phase, with memory-capacity expansions shift...
Nvidia’s shares lag the broader chip rally even as demand for AI accelerates, prompting questions about earnings timi...